secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2023-04-11T23:59:59+00:00
Accession:  0001140361-23-017671
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna Therapeutics secures up to $10M equity line from Lincoln Park Capital
----------------------------------------------------------------------------

- Lincoln Park committed to buy up to $10M of common stock over 24 months at Company's discretion.
- Company issued 73,659 shares as commitment fee; purchases subject to volume and price limits.
- No upper limit on purchase price per share; Lincoln Park cannot short or hedge during term.
- Sales limited to 19.99% of outstanding shares unless stock price exceeds $3.6094 or shareholder approval obtained.
- Company may terminate agreement with one business day notice; no penalties or liquidated damages.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000114036123017671/0001140361-23-017671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000114036123017671/brhc10050812_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-017671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer